Publikationen in Zusammenarbeit mit Forschern von VU University Amsterdam (35)

2024

  1. Corrigendum to “ESPEN micronutrient guideline” [Clin Nutr 41 (2022) 1357–1424/YCLNU5151, (S0261561422000668), (10.1016/j.clnu.2022.02.015)]

    Clinical Nutrition

  2. ESPEN practical short micronutrient guideline

    Clinical Nutrition, Vol. 43, Núm. 3, pp. 825-857

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 469-477

  3. Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

    Alzheimer's and Dementia, Vol. 19, Núm. 12, pp. 5817-5836

  4. Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission

    British Journal of Haematology, Vol. 201, Núm. 6, pp. 1169-1178

  5. Impact of stenosis resistance and coronary flow capacity on fractional flow reserve and instantaneous wave-free ratio discordance: a combined analysis of DEFINE-FLOW and IDEAL

    Netherlands Heart Journal, Vol. 31, Núm. 11, pp. 434-443

  6. Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma

    Future Oncology, Vol. 19, Núm. 12, pp. 811-818

2022

  1. A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients

    Drugs and Aging, Vol. 39, Núm. 11, pp. 863-874

  2. ESPEN micronutrient guideline

    Clinical Nutrition, Vol. 41, Núm. 6, pp. 1357-1424

  3. Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial

    European heart journal, Vol. 43, Núm. 38, pp. 3732-3745

  4. Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib

    Cancers, Vol. 14, Núm. 12

  5. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

    American Journal of Hematology

  6. Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

    Trials, Vol. 23, Núm. 1

  7. Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer

    ESMO Open, Vol. 7, Núm. 2

  8. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

    Journal of Clinical Oncology, Vol. 364

2021

  1. Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability

    Peritoneal Dialysis International, Vol. 41, Núm. 6, pp. 533-541

  2. Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials (European Journal of Clinical Pharmacology, (2021), 77, 1, (1-12), 10.1007/s00228-020-02951-8)

    European Journal of Clinical Pharmacology

  3. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

    European Journal of Clinical Pharmacology, Vol. 77, Núm. 1

  4. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1